Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials

2 RCTs (n=123 and n=122) found that the incidence of of hypophosphatemia was significantly lower following iron isomaltoside vs ferric carboxymaltose (trial A: 7.9% vs 75.0% p<0.001; trial B: 8.1% vs 73.7%, p<0.001; for both).


Journal of the American Medical Association